Document is current
Any future updates will be listed below
-
Authors
Brenner, Jacqueline L.
Anibal, James T.
Hazen, Lindsey A.
Song, Miranda J.
Huth, Hannah B.
Xu, Daguang
Xu, Sheng
Wood, Bradford J.
-
Funding
Funding for this research was provided by:
NIH Center for Interventional Oncology (Z1A CL040015, 1ZIDBC011242)
- License Information
-
More Information
Article History
Received: 10 July 2024
Accepted: 12 December 2024
First Online: 26 March 2025
Declarations
:
: The authors declare no competing non-financial interests but the following competing financial interests. NIH may own intellectual property in the field. NIH and BJW receive royalties for licensed patents from Philips, unrelated to this work. BW is Principal Investigator on the following CRADA’s = Cooperative Research & Development Agreements, between NIH and industry: Philips, Philips Research, Celsion Corp, BTG Biocompatibles / Boston Scientific, Siemens Healthineers / Varian Interventional Systems, NVIDIA, Canon, XACT Robotics. Mediview, Deep Sight, Uro-1, Promaxo. The following industry partners also support research in CIO lab via equipment, personnel, devices and/ or drugs: 3 T Technologies (devices), Exact Imaging (data), AngioDynamics (equipment), AstraZeneca (pharmaceuticals, NCI CRADA), ArciTrax (devices and equipment), Imactis/ GE (Equipment), Johnson & Johnson (equipment), Medtronic (equipment), Theromics (Supplies), Profound Medical (equipment and supplies), QT Imaging (equipment and supplies), Combat Medical (equipment). DX is an employee of NVIDIA. The content of this manuscript does not necessarily reflect the views, policies, or opinions of the National Institutes of Health (NIH) or the U.S. Department of Health and Human Services. The mention of commercial products, their source, or their use in connection with material reported herein is not to be construed as an actual or implied endorsement of such products by the U.S. government.
